AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 100 filers reported holding AVROBIO INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $0 | -100.0% | 320 | -97.4% | 0.00% | – |
Q1 2022 | $16,000 | -66.0% | 12,320 | 0.0% | 0.00% | – |
Q4 2021 | $47,000 | -31.9% | 12,320 | -0.2% | 0.00% | – |
Q3 2021 | $69,000 | -72.8% | 12,346 | -56.8% | 0.00% | – |
Q2 2021 | $254,000 | -29.2% | 28,601 | +1.1% | 0.00% | – |
Q1 2021 | $359,000 | -9.1% | 28,300 | 0.0% | 0.00% | – |
Q4 2020 | $395,000 | +7.3% | 28,300 | 0.0% | 0.00% | – |
Q3 2020 | $368,000 | -25.5% | 28,300 | 0.0% | 0.00% | -100.0% |
Q2 2020 | $494,000 | +75.2% | 28,300 | +56.4% | 0.00% | – |
Q1 2020 | $282,000 | -22.5% | 18,100 | 0.0% | 0.00% | – |
Q4 2019 | $364,000 | +42.2% | 18,100 | 0.0% | 0.00% | – |
Q3 2019 | $256,000 | +23.1% | 18,100 | +41.4% | 0.00% | – |
Q2 2019 | $208,000 | +38.7% | 12,800 | +88.2% | 0.00% | – |
Q1 2019 | $150,000 | +32.7% | 6,800 | 0.0% | 0.00% | – |
Q4 2018 | $113,000 | – | 6,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 2,736,027 | $45,555,000 | 28.05% |
Aisling Capital Management LP | 736,998 | $12,271,000 | 12.93% |
Cormorant Asset Management, LP | 1,357,784 | $22,607,000 | 1.84% |
New Leaf Venture Partners, L.L.C. | 215,550 | $3,589,000 | 0.98% |
Eventide Asset Management | 928,891 | $14,901,000 | 0.66% |
EMERALD ADVISERS, LLC | 380,636 | $6,338,000 | 0.31% |
EMERALD MUTUAL FUND ADVISERS TRUST | 372,865 | $6,208,000 | 0.29% |
Blackstone Inc. | 2,962,325 | $49,323,000 | 0.28% |
PFM Health Sciences, LP | 241,413 | $4,020,000 | 0.11% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 143,762 | $2,394,000 | 0.10% |